A Phase II Trial of Bexarotene for Advanced Differentiated Thyroid Cancer

Thyroid. 2015 May;25(5):563-4. doi: 10.1089/thy.2014.0399. Epub 2015 Apr 7.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma, Follicular / drug therapy*
  • Aged
  • Anticarcinogenic Agents / therapeutic use*
  • Bexarotene
  • Carcinoma, Papillary / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Tetrahydronaphthalenes / therapeutic use*
  • Thyroid Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • Anticarcinogenic Agents
  • Tetrahydronaphthalenes
  • Bexarotene